End-to-End Biologics CDMO Manufacturing Capacity|OPM Biosciences

End-to-End Biologics CDMO Development Center

Focus on drug discovery, offering preclinical process development and clinical manufacturing services, equipped with two 200L/500L production lines
Customized media solutions, transient transfection platform
A comprehensive platform for cell line development, process development and antibody quality analysis

With two 2000L production lines, two 500L production lines and two 200L production lines, the manufacturing capacity can reach 5400L
Use of disposable bioreactors to reduce the possibility of cross-contamination, resulting in rapid and flexible production of different products

Building #28, 908 Ziping Road, Pudong, Shanghai, China

+86 021-2078 0255 (General)

+86 021-6818 2622 (Salesline)

+86 021-6810 1106 (CDMO BD)